Clinical Trial Update: Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA).

View source ↗

Summary

Overview of a clinical trial evaluating anti-citrullinated SR-A peptide (Anti-csp) antibody as a biomarker for rheumatoid arthritis. The study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Walaa sharif Eid Ahmed | Conditions: Rheumatoid Arthritis (RA) | Status: NOT_YET_RECRUITING